Comparative efficacy of once-weekly semaglutide versus SGLT-2 inhibitors in patients inadequately controlled with one to two oral antidiabetic drugs: a systematic literature review and network meta-analysis.

Kanters, Steve; Wilkinson, Lars; Vrazic, Hrvoje; Sharma, Rohini; Lopes, Sandra; Popoff, Evan; Druyts, Eric

Kanters, Steve; Wilkinson, Lars; Vrazic, Hrvoje; Sharma, Rohini; Lopes, Sandra; Popoff, Evan; Druyts, Eric.

Affiliation

Kanters S; Precision Xtract, Vancouver, British Columbia, Canada.
Wilkinson L; Novo Nordisk A/S, Søborg, Denmark.
Vrazic H; Novo Nordisk A/S, Søborg, Denmark.
Sharma R; Precision Xtract, Vancouver, British Columbia, Canada.
Lopes S; Novo Nordisk A/S, Søborg, Denmark.
Popoff E; Precision Xtract, Vancouver, British Columbia, Canada.
Druyts E; Precision Xtract, Vancouver, British Columbia, Canada.

BMJ Open ; 9(7): e023458, 2019 07 23.

Article in En | MEDLINE | ID: mdl-31340953

Subject(s)

Diabetes Mellitus, Type 2/drug therapy; Glucagon-Like Peptides/administration & dosage; Hypoglycemic Agents/administration & dosage; Sodium-Glucose Transporter 2 Inhibitors/administration & dosage; Benzhydryl Compounds; Canagliflozin; Glucagon-Like Peptides/therapeutic use; Glucosides; Humans; Hypoglycemic Agents/therapeutic use; Metformin; Network Meta-Analysis; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use; Treatment Outcome

Key words

SGLT-2 inhibitors; glucagon-like peptide-1 analogue; once-weekly semaglutide; sustain clinical trial programme; type 2 diabetes

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Glucagon-Like Peptides / Sodium-Glucose Transporter 2 Inhibitors / Hypoglycemic Agents Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: BMJ Open Year: 2019 Type: Article Affiliation country: Canada

Fulltext

XML

PubMed Links

Search on Google